DEA launches SORS as vehicle to report suspicious drug orders

NCPA November 11, 2019

Last week, the DEA launched the Suspicious Orders Report System Online, a centralized database required by the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act, also known as the SUPPORT Act. The purpose of the database is for DEA-registered distributors to report suspicious orders pursuant to the law. The SUPPORT Act states the term "suspicious order" may include, but is not limited to: an order of a controlled substance of unusual size; an order of a controlled substance deviating substantially from a normal pattern; and orders of controlled substances of unusual frequency under the law. Pharmacies will only need to report to the database if they are registered distributors with the DEA.